3 results
Approved WMOCompleted
To provide idelalisib, a marketed PI3K* inhibitor, in lieu of GS-9820, an investigational second generation PI3K* inhibitor, to subjects receiving GS-9820 in Study GS-US-315-0102 at the time of study closure.
Approved WMORecruiting
To collect clinical and device performance outcomes data with the ACURATE neo2* Transfemoral Aortic Valve System as used inroutine clinical practice for the treatment of severe calcific aortic stenosis.
Approved WMOPending
In this pilot study we want to evaluate the clinical use of the DiffMag handheld probe, and compare the detection and usability of the DiffMag with the radioactive detection and the detection of the SentiMag for furthur optimazation of DiffMag…